7.18 USD
↘ 0.04 (0.55%)AT CLOSE (11:59 AM EDT)
AtaiBeckley Inc. Common Stock
ATAINASDAQ • USD
7.19
↗ 0.01 (0.14%)
POST MARKET (AS OF 07:45 PM EDT)
Post Market
AS OF 07:45 PM EDT
7.19
↗ 0.01 (0.14%)
Market: CLOSED
ATAI is currently priced at $7.21. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 6, 2026.
Open?$7.20
High?$7.22
Low?$7.18
Prev. Close?$7.22
Volume?4.4M
Avg. Volume?N/A
VWAP?$7.21
Bid / Ask
Bid?$7.17 × 100
Ask?$7.22 × 100
Spread?$0.05
Midpoint?$7.20
Valuation & Ratios
Market Cap?2.7B
Shares Out?368.2M
Float?298.7M
Float %?81.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Employees
99
Market Cap
2.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-06-18
Address
C/O ATAI LIFE SCIENCES US, INC.
NEW YORK, NY 10119
Phone: 1 929 207 2670
NEW YORK, NY 10119
Phone: 1 929 207 2670
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?12.65%High
Short Interest?37.8M
Days to Cover?4.0
Free Float298.7M
Avg Daily Volume9.4M
Settlement Date2026-07-15